The preparation of nasal glucagon is immediate and intended for use in an emergency hypoglycemic event, but how well can it reverse these events?
Read More »Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval
With the introduction of this new biosimilar insulin, patients with diabetes will have the opportunity to have easier and broader access to insulin therapy, and a more affordable option than those already on the market.
Read More »Effects of Basal Insulin on Lipids vs. Other Antihyperglycemics
How does basal insulin compare to other diabetes medications in its impact on cholesterol and triglycerides?
Read More »ADA 2021: Long-term Safety of Intranasal Insulin in Insulin-Dependent Type 2 Diabetes
Researchers assess the safety of intranasal insulin as a treatment for type 2 diabetes-associated cognitive impairment in aging adult populations.
Read More »ADA 2021: Infusion Set Survival and Performance of Medtronic Extended-Wear Infusion Set
Real-world data for the Medtronic Extended-Wear Infusion Set revealed at the 81st American Diabetes Association scientific session.
Read More »ADA 2021: Effectiveness of Liraglutide and Insulin Based on GRADE Study
The GRADE Study is the most comprehensive study comparing multiple diabetic medications to assess efficacy in type 2 diabetes. So which drug therapy reigned supreme?
Read More »Prevent Infection Transmission During Assisted Glucose Monitoring
Several warnings have been issued by the CDC regarding unsafe practices that might result in the transmission of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and other infectious diseases during assisted blood glucose monitoring and insulin administration.
Read More »Type 1 Diabetes and New Innovations
A century after the discovery of insulin, new insulins, new devices, and other innovations may again change the future of treatment for type 1 diabetes.
Read More »Adding Pramlintide to Artificial Pancreas Systems
The pancreas secretes both insulin and amylin, so should an artificial pancreas system provide insulin and pramlintide?
Read More »Impact of Intensive Insulin Therapy on Diabetic Retinopathy
Intensive insulin therapy may speed up the development of diabetic retinopathy, placing some patients at a higher risk for blindness.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.